| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2009/05/06 | 05:00 | Business Wire | Allos Therapeutics Reports First Quarter 2009 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/04/30 | 21:31 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/04/29 | 05:00 | Business Wire | Allos Therapeutics to Report First Quarter 2009 Results on May 5, 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/04/20 | 20:54 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/04/20 | 04:00 | Business Wire | Allos Therapeutics’ Pralatrexate Demonstrates Anticancer Activity in Multiple Cancer Cell Lines | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/04/15 | 21:00 | Business Wire | Allos Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/04/04 | 05:05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/04/04 | 05:00 | Business Wire | Allos Therapeutics Announces Closing of Common Stock Offering | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/04/03 | 05:14 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/04/03 | 05:10 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/31 | 22:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/31 | 22:00 | Business Wire | Allos Therapeutics Announces Pricing of Common Stock Offering | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/28 | 06:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/26 | 21:00 | Business Wire | Allos Therapeutics to Present at the 4th Annual Citi Biotech Day | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/25 | 21:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/25 | 21:00 | Business Wire | Allos Therapeutics Submits New Drug Application for Pralatrexate for Patients with Relapsed or Refractory Peripheral T-cell L... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/25 | 06:30 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/24 | 21:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/24 | 21:00 | Business Wire | Allos Therapeutics Appoints David M. Stout to Its Board of Directors | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/21 | 05:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/17 | 21:08 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/17 | 21:00 | Business Wire | Allos Therapeutics’ Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Bladder Cancer by the Eu... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/17 | 07:29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/17 | 07:27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/17 | 07:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/13 | 05:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/04 | 06:03 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/03/04 | 06:00 | Business Wire | Allos Therapeutics Reports 2008 Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/02/28 | 06:52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/02/27 | 06:00 | Business Wire | Allos Therapeutics to Report 2008 Results on March 3, 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |